Providing members with education and information about prostate cancer is an important part of the Group’s activities
Meetings are currently being held via Zoom, and are working well.
The guest speaker at our December 2020 Zoom meeting will be Dr Cleola Anderiesz, Deputy Chief Executive Officer at Cancer Australia. Check the December 2020 Newsletter a week or so before the meeting for the Zoom access details.
Dr Cleola Anderiesz, Deputy Chief Executive Officer at Cancer Australia, is an experienced senior executive with 18 years of experience in health across the research, not-for-profit, and government public sector. Committed to quality in healthcare, Dr Anderiesz holds a PhD in Medicine and a Senior Executive MBA. She is skilled in policy, strategy, innovation, program development and implementation, stakeholder engagement, and evidence-based decision making.
The guest speaker at our October 2020 meeting on Tuesday October 20 was Dr Renu Eapen.
Dr Eapen is a Consultant Urologist who privately consults at Cancer Specialists, and operates and consults at the Peter MacCallum Cancer Centre. She has a special interest in the surgical and non-surgical management of prostate cancer, as well as kidney and bladder cancers. She also has an interest in the treatment of voiding dysfunction in men and women.
Dr Eapen completed her urology training with the Royal Australasian College of Surgeons in 2014 and then undertook research in Female Pelvic Medicine and Reconstructive Surgery at the University of Texas Southwestern. She went on to complete Fellowship training in urodynamics, incontinence voiding dysfunction and reconstruction at the University of Toronto, and then in robotics and uro-oncology at the University of California at San Francisco.
The guest speaker at our August 2020 meeting on Tuesday August 18 was urologist Mr David Dangerfield.
Mr Dangerfield is at the forefront of establishing a new microsurgery procedure to restore potency to men who have had the erectile nerve connections to their penis damaged after having their prostate removed as a result of cancer.